SCHEMBL19952967

SCHEMBL19952967

CCC(COC)Nc1nc(C)nc(Oc2ccc(Cl)cc2C)c1C

nearest known ligand 0.45

Predicted protein targets (top 4)

geneUniProtsupporting neighboursconfidence
CRHR1 P34998 17/20 0.45
TAS1R3 Q7RTX0 1/20 0.37
TAS1R1 Q7RTX1 1/20 0.37
L3MBTL1 Q9Y468 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19953004 0.87 CRHR1 (0.56) CRHR1
SCHEMBL21447166 0.80 CRHR1 (0.55) CRHR1
SCHEMBL21447452 0.76 CRHR1 (0.43) CRHR1
SCHEMBL20573505 0.74 CRHR1 (0.68) CRHR1
SCHEMBL5844690 0.72 CRHR1 (0.42) CRHR1
SCHEMBL25282101 0.72 CRHR1 (0.41) CRHR1TAS1R3TAS1R1
SCHEMBL19952797 0.71 L3MBTL1 (0.48) L3MBTL1
SCHEMBL21447121 0.71 CRHR1 (0.36) CRHR1
SCHEMBL5844100 0.70 CRHR1 (0.64) CRHR1
SCHEMBL7214597 0.70 CRHR1 (0.55) CRHR1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3510029-B1 ALLOSTERIC CORTICOTROPIN-RELEASING FACTOR RECEPTOR 1 (CRFR1) ANTAGONISTS THAT DECREASE P-TAU AND IMPROVE COGNITION UNIV CALIFORNIA (US) 2025-11-05 EP disclosed
CN-109906222-B Allosteric corticotropin releasing factor receptor 1 (CRFR 1) antagonists that reduce P-TAU and improve cognition 加利福尼亚大学董事会 2023-08-01 CN disclosed
US-11077108-B2 Allosteric corticotropin-releasing factor receptor 1 (CRFR1) antagonists that decrease p-tau and improve cognition THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) 2021-08-03 US disclosed
US-11077108-B2 Allosteric corticotropin-releasing factor receptor 1 (CRFR1) antagonists that decrease p-tau and improve cognition THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) 2021-08-03 US disclosed
US-20190307747-A1 ALLOSTERIC CORTICOTROPIN-RELEASING FACTOR RECEPTOR 1 (CRFR1) ANTAGONISTS THAT DECREASE P-TAU AND IMPROVE COGNITION THE REGENTS OF THE UNIVERSITY OF CALIFORNIA 2019-10-10 US disclosed
US-20190307747-A1 ALLOSTERIC CORTICOTROPIN-RELEASING FACTOR RECEPTOR 1 (CRFR1) ANTAGONISTS THAT DECREASE P-TAU AND IMPROVE COGNITION THE REGENTS OF THE UNIVERSITY OF CALIFORNIA 2019-10-10 US disclosed
EP-3510029-A1 ALLOSTERIC CORTICOTROPIN-RELEASING FACTOR RECEPTOR 1 (CRFR1) ANTAGONISTS THAT DECREASE P-TAU AND IMPROVE COGNITION The Regents of The University of California (US) 2019-07-17 EP disclosed
WO-2018048953-A1 ALLOSTERIC CORTICOTROPIN-RELEASING FACTOR RECEPTOR 1 (CRFR1) ANTAGONISTS THAT DECREASE P-TAU AND IMPROVE COGNITION THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) 2018-03-15 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11077108-B2 Allosteric corticotropin-releasing factor receptor 1 (CRFR1) antagonists that decrease p-tau and improve cognition CRHR1, CRH, CRHR2 CRHR1 1/4885TAS1R3 701/4885TAS1R1 621/4885
US-20190307747-A1 ALLOSTERIC CORTICOTROPIN-RELEASING FACTOR RECEPTOR 1 (CRFR1) ANTAGONISTS THAT DECREASE P-TAU AND IMPROVE COGNITION CRHR1, CRH, CRHR2 CRHR1 1/4885TAS1R3 1017/4885TAS1R1 887/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.